Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 06, 2024

BUY
$71.58 - $87.29 $247,308 - $301,586
3,455 New
3,455 $253,000
Q4 2023

Aug 06, 2024

BUY
$73.27 - $83.09 $234,024 - $265,389
3,194 New
3,194 $258,000
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $234,024 - $265,389
3,194 New
3,194 $258,000
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $777,678 - $977,795
-12,523 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $905,913 - $1.05 Million
12,523 New
12,523 $964,000
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $707,871 - $830,940
-9,949 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $717,422 - $850,341
9,949
9,949 $806,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.